Answers are grounded in this paper and cite their sources.
Untargeted metabolomics based on Ultra High-Performance Liquid Chromatography coupled to High-Resolution Mass Spectrometry (UHPLC-HRMS) is a powerful tool widely used in various research domains, including large-scale clinical studies. However, current approaches for comparing untargeted metabolomic methods typically rely on a limited set of representative analytes due to their high cost and limited availability, potentially introducing bias given the vast chemical diversity of the detectable metabolome. This study proposes a data-driven strategy to systematically compare and rank untargeted UHPLC-HRMS methodologies by leveraging metabolite annotations from the public reference spectral libraries deposited in the Global Natural Products Social molecular network (GNPS) as a proxy for chemical coverage. We assessed 23 methodologies: 15 reverse-phase and 8 HILIC-phase from six metabolomic platforms using commercial human serum samples. Across all methods, a combined total of 2448 unique metabolites were annotated at MSI level 2, covering 57 chemical classes and 13 superclasses, as defined by the ClassyFire ontology. Methods were ranked using a weighted composite system incorporating reproducibility (RSD <30%), linearity (Pearson r > 0.9), and chemical diversity coverage quantified by the Shannon diversity index. The reliability of GNPS-based annotations was validated against 129 metabolites for which authentic standards were available in our in-house library, all of which were correctly confirmed, supporting the reliability of the MSI level 2 annotations. Applied to clinical serum samples from the PrevenDIAB study, the best-performing method combination (P1−H and P6−C18) detected 883 metabolites meeting both quality criteria, of which 98% were shared with the commercial serum results. Our findings demonstrate that this framework provides a practical, scalable, and cost-effective complementary approach to standard-based validation for the comparative evaluation of untargeted metabolomics methods.
No takes yet. Share an insight, caveat, or question.
Pacheco‐Tapia et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: